131 related articles for article (PubMed ID: 11108789)
1. Diverse signalling by 5-hydroxytryptamine (5-HT) receptors.
Pauwels PJ
Biochem Pharmacol; 2000 Dec; 60(12):1743-50. PubMed ID: 11108789
[TBL] [Abstract][Full Text] [Related]
2. Heterologous desensitization is evoked by both agonist and antagonist stimulation of the human 5-HT(7) serotonin receptor.
Krobert KA; Andressen KW; Levy FO
Eur J Pharmacol; 2006 Feb; 532(1-2):1-10. PubMed ID: 16487959
[TBL] [Abstract][Full Text] [Related]
3. RNA-editing of the 5-HT(2C) receptor alters agonist-receptor-effector coupling specificity.
Berg KA; Cropper JD; Niswender CM; Sanders-Bush E; Emeson RB; Clarke WP
Br J Pharmacol; 2001 Sep; 134(2):386-92. PubMed ID: 11564657
[TBL] [Abstract][Full Text] [Related]
4. Activation of constitutive 5-hydroxytryptamine(1B) receptor by a series of mutations in the BBXXB motif: positioning of the third intracellular loop distal junction and its G(o)alpha protein interactions.
Pauwels PJ; Gouble A; Wurch T
Biochem J; 1999 Oct; 343 Pt 2(Pt 2):435-42. PubMed ID: 10510311
[TBL] [Abstract][Full Text] [Related]
5. Serotonin 5-hydroxytryptamine 2A receptor-coupled phospholipase C and phospholipase A2 signaling pathways have different receptor reserves.
Kurrasch-Orbaugh DM; Watts VJ; Barker EL; Nichols DE
J Pharmacol Exp Ther; 2003 Jan; 304(1):229-37. PubMed ID: 12490596
[TBL] [Abstract][Full Text] [Related]
6. Antibody capture assay reveals bell-shaped concentration-response isotherms for h5-HT(1A) receptor-mediated Galpha(i3) activation: conformational selection by high-efficacy agonists, and relationship to trafficking of receptor signaling.
Newman-Tancredi A; Cussac D; Marini L; Millan MJ
Mol Pharmacol; 2002 Sep; 62(3):590-601. PubMed ID: 12181435
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological properties of 5-Hydroxytryptamine(4) receptor antagonists on constitutively active wild-type and mutated receptors.
Claeysen S; Sebben M; Bécamel C; Eglen RM; Clark RD; Bockaert J; Dumuis A
Mol Pharmacol; 2000 Jul; 58(1):136-44. PubMed ID: 10860935
[TBL] [Abstract][Full Text] [Related]
8. Regulation of serotonin-2C receptor G-protein coupling by RNA editing.
Burns CM; Chu H; Rueter SM; Hutchinson LK; Canton H; Sanders-Bush E; Emeson RB
Nature; 1997 May; 387(6630):303-8. PubMed ID: 9153397
[TBL] [Abstract][Full Text] [Related]
9. Altered G protein-coupling functions of RNA editing isoform and splicing variant serotonin2C receptors.
Wang Q; O'Brien PJ; Chen CX; Cho DS; Murray JM; Nishikura K
J Neurochem; 2000 Mar; 74(3):1290-300. PubMed ID: 10693963
[TBL] [Abstract][Full Text] [Related]
10. 5-hydroxytryptamine (5-HT) receptor ligands.
Kitson SL
Curr Pharm Des; 2007; 13(25):2621-37. PubMed ID: 17897004
[TBL] [Abstract][Full Text] [Related]
11. RNA editing of the human serotonin 5-HT2C receptor alters receptor-mediated activation of G13 protein.
Price RD; Weiner DM; Chang MS; Sanders-Bush E
J Biol Chem; 2001 Nov; 276(48):44663-8. PubMed ID: 11572865
[TBL] [Abstract][Full Text] [Related]
12. Messenger RNA editing of the human serotonin 5-HT2C receptor.
Fitzgerald LW; Iyer G; Conklin DS; Krause CM; Marshall A; Patterson JP; Tran DP; Jonak GJ; Hartig PR
Neuropsychopharmacology; 1999 Aug; 21(2 Suppl):82S-90S. PubMed ID: 10432493
[TBL] [Abstract][Full Text] [Related]
13. Decreased agonist, but not antagonist, binding to the naturally occurring Thr92Lys variant of the h5-HT7(a) receptor.
Brüss M; Kiel S; Bönisch H; Kostanian A; Göthert M
Neurochem Int; 2005 Aug; 47(3):196-203. PubMed ID: 15896881
[TBL] [Abstract][Full Text] [Related]
14. Identification and Pharmacological Characterization of Two Serotonin Type 7 Receptor Isoforms from
Chen W; Gao X; Wang H; Xie G; An S; Du Y; Zhao X
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614100
[TBL] [Abstract][Full Text] [Related]
15. A conservative, single-amino acid substitution in the second cytoplasmic domain of the human Serotonin2C receptor alters both ligand-dependent and -independent receptor signaling.
Berg KA; Dunlop J; Sanchez T; Silva M; Clarke WP
J Pharmacol Exp Ther; 2008 Mar; 324(3):1084-92. PubMed ID: 18065501
[TBL] [Abstract][Full Text] [Related]
16. Inverse agonists and serotonergic transmission: from recombinant, human serotonin (5-HT)1B receptors to G-protein coupling and function in corticolimbic structures in vivo.
Millan MJ; Gobert A; Audinot V; Dekeyne A; Newman-Tancredi A
Neuropsychopharmacology; 1999 Aug; 21(2 Suppl):61S-67S. PubMed ID: 10432490
[TBL] [Abstract][Full Text] [Related]
17. Differential activation of Gq/11 and Gi(3) proteins at 5-hydroxytryptamine(2C) receptors revealed by antibody capture assays: influence of receptor reserve and relationship to agonist-directed trafficking.
Cussac D; Newman-Tancredi A; Duqueyroix D; Pasteau V; Millan MJ
Mol Pharmacol; 2002 Sep; 62(3):578-89. PubMed ID: 12181434
[TBL] [Abstract][Full Text] [Related]
18. Signalling pathways activated by 5-HT(1B)/5-HT(1D) receptors in native smooth muscle and primary cultures of rabbit renal artery smooth muscle cells.
Hinton JM; Hill P; Jeremy J; Garland C
J Vasc Res; 2000; 37(6):457-68. PubMed ID: 11146399
[TBL] [Abstract][Full Text] [Related]
19. The atypical antipsychotics clozapine and olanzapine promote down-regulation and display functional selectivity at human 5-HT7 receptors.
Andressen KW; Manfra O; Brevik CH; Ulsund AH; Vanhoenacker P; Levy FO; Krobert KA
Br J Pharmacol; 2015 Aug; 172(15):3846-60. PubMed ID: 25884989
[TBL] [Abstract][Full Text] [Related]
20. Serotonin mechanisms in heart valve disease II: the 5-HT2 receptor and its signaling pathway in aortic valve interstitial cells.
Xu J; Jian B; Chu R; Lu Z; Li Q; Dunlop J; Rosenzweig-Lipson S; McGonigle P; Levy RJ; Liang B
Am J Pathol; 2002 Dec; 161(6):2209-18. PubMed ID: 12466135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
